Safety information

United Kingdom ／ MHRA / PMCPA

An advertisement directed at persons qualified to prescribe or supply must include the entries, or a succinct statement of the entries, in the summary of product characteristics relating to adverse reactions, precautions, contra-indications, dosage and method of administration.

医療従事者向け広告には、製品概要（SmPC）の副作用・注意事項・禁忌・用法用量に関する記載またはその簡潔な要約を含めなければならない。

statuteHuman Medicines Regulations 2012 (SI 2012/1916), Schedule 30, paragraph 7checked 2026-09-23

Note
Applied through regulation 294(2)(a). For pharmacy and general sale medicines, regulation 294(2A) allows a shortened advertisement carrying a stated sentence plus a website address that makes the Schedule 30 particulars or the SmPC available.

The same topic elsewhere

Japan ── In sales information provision activities a company must provide necessary saf…United States ── Every prescription drug advertisement other than the listed exempt advertiseme…Canada ── Risk information must be given prominence comparable to benefit in the main bo…European Union ── Advertising to persons qualified to prescribe or supply must include essential…China ── A drug advertisement must prominently state the contraindications and the adve…Australia ── An advertisement about therapeutic goods must not contain any statement, picto…Korea ── For a drug that has adverse reactions, no advertisement may use expressions th…Switzerland ── Every advertisement must contain at least a summary of the restrictions on use…